Primary Job Title Member of the Board of Directors Primary Organization 
Spectris
Location Cambridge, Cambridgeshire, United Kingdom Regions Europe, Middle East, and Africa (EMEA) Gender Male Also Known As Peter Chambré
LinkedIn View on LinkedIn
Peter Chambré has extensive experience in the pharmaceutical industry and significant board experience, having held a number of senior and non-executive positions in healthcare companies, including as chief executive officer of Cambridge Antibody Technology Group plc (until its acquisition by AstraZeneca PLC in 2006), chairman of ApaTech Limited
and non-executive director of BTG plc. Prior to that he was chief operating officer of Celera Genomics Group and chief executive of Bespak plc.
Chairman of 7TM Pharma A/S, Immatics Biotechnologies GmbH and Cancer Research Technology Ltd. Director of OneMed Sverige AB and Imperial Innovations Group plc. Trustee of Cancer Research UK.
